An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01316679

Enrollment

Registered

2011-03-16

Start date

2011-03-31

Completion date

2013-01-31

Last updated

2017-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma, Liver Disease

Keywords

HCC, Liver Disease without HCC

Brief summary

Specific urine proteases or groups of these enzymes can be reliable biomarkers and an effective gauge of response to therapy in patients with hepatocellular carcinoma.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* Ability and willingness to provide written informed consent * Must be between 18-90 years of age at the time of consent * Ability to provide urine specimen at protocol-defined timepoints * Must have treatment interventions planned that are directly related to liver disease (excluding those assigned to group 3-Controls)

Exclusion criteria

* Suspected inability, e.g. unwillingness to comply with study procedures or unwillingness to provide written consent

Outcome results